Primary record
N-(3-(3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide
- 库存
- 4,883 克
- 纯度
- 98.5 %
- CAS
- 177530-93-7
化合物标识与属性
- CAS
- 177530-93-7
- PubChem CID
- 3203
- SMILES
- C1CC1C#CC2(C3=C(C=CC(=C3)Cl)NC(=O)O2)C(F)(F)F
- Canonical SMILES
- O=C1Nc2ccc(Cl)cc2C(C#CC2CC2)(C(F)(F)F)O1
名称与同义词
- Rac-Efavirenz
- efavirenz
- Efavirenz Racemic
- (Rac)-Efavirenz
- Trametinib
- Stocrin
- Sustiva
- ent Efavirenz
- ent-Efavirenz
- rac Efavirenz
- rac Efavirenz-d4
- Efavirenz-d5
- Racemic-Efavirenz
- Efavirenz Racemate
- (+/-)-Efavirenz
- Efavirenz-13C6
- Efavirenz [racemic]
- 177530-93-7
- Efavirenz, (R)-
- YXP9JDK7R7
- C14H9ClF3NO2
- AC1L1FEN
- Efavirenz Racemic Mixture
- XPOQHMRABVBWPR-UHFFFAOYSA-N
- RefChem:1097951
- rac Efavirenz-d5 (major)
- UNII-CEE19E5D5F
- Efavirenz Racemic (20mg)
- AC1Q4K2K
- MLS001304019
- MLS006011825
- CHEMBL59507
- L 741211
- SCHEMBL464769
- orb1695530
- CTK4C8360
- CID3203
- DMP 266
- DMP-266
- DTXSID00861416
- C14-H9-Cl-F3-N-O2
- HMS2231D09
- HMS3373J19
- HMS5083O14
- KST-1A2162
- HVB64295
- PS-J-002
- WZB81258
- Tox21 111582
- AR-1A0048
- BBL010771
- HY-10572B
- MFCD00927196
- s4685
- STK582240
- STL454184
- 6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one
- AKOS005506207
- 6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
- TRA0009432
- L-741211
- NCGC00159337-02
- NCGC00159337-03
- NCGC00159337-06
- 154635-17-3
- FC100188
- SMR000718784
- VS-02672
- L 743725
- LS-173466
- CS-0092492
- FT-0625647
- FT-0667824
- L741211
- T8925
- 154598-52-4
- J3.113.316E
- AB00876268-06
- 6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1H-benzo[d][1,3]oxazin-2(4H)-one
- L743725
- 154801-74-8
- I06-0061
- L 743726
- L-743726
- 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-
- L 743,726
- L-743,726
- 6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one
- 6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
- (-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE
- 1814-69-3
- 2H-3,1-Benzoxazin-2-one,6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-
- 6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-3-one
- 1132642-95-5
- 1246812-58-7
- 6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one
- (+) 6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl- 1,4-dihydro-2H-3,1-benzoxazin-2-one
- (+) 6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
- (+/-) 6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
- (+/-)6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one
- (4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one
- 2h-3,1-benzoxazin-2-ona, 6-cloro-4-(2-ciclopropiletinil)-1,4-dihidro-4-(trifluorometil)-
- 6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
- 6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
- 6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-4H-3,1-benzoxazin-2-ol
- 6-Chloro-4-(trifluoromethyl)-4-(cyclopropylethynyl)-1,4-dihydro-2H-3,1-benzooxazine-2-one
- (4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one
- 1261394-62-0
- 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-
- 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-
- 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (+-)-
- 2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (R)-
- 871700-17-3
- Efavirenz Racemic; ((+/-)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one)
- N-(3-(3-cyclopropyl-5-(2-fluoro-4-iodophenylamino)-6,8-dimethyl-2,4,7-trioxo-3,4,6,7-tetrahydropyrido[4,3-d]pyrimidin-1(2H)-yl)phenyl)acetamide